Bausch + Lomb Q2 FY26 GAAP net loss narrows to $14 million; revenue rises 9% to $1.39 billion - BLCO News | RalliesBausch + Lomb Q2 FY26 GAAP net loss narrows to $14 million; revenue rises 9% to $1.39 billion
B
BLCO• Second-quarter results
- Second-quarter revenue rose 9% to $1.39 billion.
- Net loss attributable to shareholders narrowed to $14 million from $62 million; GAAP EPS improved to a loss of $0.04.
- Operating income swung to $83 million from an operating loss of $11 million; adjusted EBITDA (non-GAAP) climbed to $241 million from $191 million.
Segment performance and outlook
- Segment revenue rose 4% to $784 million in Vision Care, 19% to $256 million in Surgical, and 15% to $354 million in Pharmaceuticals.
- Raised 2026 revenue outlook to $5.44 billion-$5.54 billion; lifted adjusted EBITDA excluding acquired IPR&D (non-GAAP) to $1.03 billion-$1.08 billion.
•
